Latest GRTX reports update at 2024-05-13: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Galera Therapeutics GRTX

$ 0.14 -32.59%

Galera Therapeutics Income Statement 2011-2024 | GRTX

Annual Income Statement Galera Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	7.61 M	53.3 M	72.5 M	280 M	345 M	-	-	-	-	-	-	-	-
Shares	54.4 M	28.5 M	26.5 M	24.9 M	24.8 M	-	-	-	-	-	-	-	-
Historical Prices	0.14	1.87	2.74	11.2	14.8	-	-	-	-	-	-	-	-
Net Income	-59.1 M	-62.2 M	-80.5 M	-74.2 M	-51.9 M	-23.7 M	-23.5 M	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-49.3 M	-51.2 M	-73.4 M	-70.6 M	-50.7 M	-24.3 M	-	-	-	-	-	-	-
Interest Expense	11.4 M	11.6 M	7.19 M	4.88 M	3.03 M	220 K	-	-	-	-	-	-	-
EBITDA	-49 M	-51.1 M	-72.6 M	-70.2 M	-50.4 M	-23.5 M	-23.8 M	-	-	-	-	-	-
Operating Expenses	-	-	-	70.6 M	50.7 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	22.8 M	20.2 M	21 M	15.7 M	8.36 M	5.59 M	3.5 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Galera Therapeutics

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	54.4 M	54.4 M	45.5 M	42.9 M	35.2 M	28.5 M	26.8 M	26.8 M	26.7 M	26.5 M	26.3 M	25.4 M	25 M	25 M	24.9 M	24.8 M	24.8 M	24.8 M	301 K	301 K	301 K	301 K	301 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-4.38 M	-	-15.1 M	-20.7 M	-17.7 M	-	-16 M	-14.6 M	-15.4 M	-	-22.6 M	-22.4 M	-18.7 M	-	-17.1 M	-18.7 M	-18.4 M	-	-13.4 M	-11.6 M	-10.3 M	-	-5.25 M	-4.33 M	-5.53 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-4.58 M	-	-13.4 M	-16.8 M	-13.9 M	-	-13 M	-11.9 M	-13.2 M	-	-20.3 M	-21.1 M	-17.5 M	-	-16.1 M	-17.7 M	-17.8 M	-	-12.9 M	-11.3 M	-10.4 M	-	-5.41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-2.09 M	4.4 M	4.22 M	-	3.24 M	2.7 M	2.3 M	-	2.33 M	1.3 M	1.25 M	-	1.24 M	1.3 M	1.1 M	-	918 K	736 K	439 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-4.57 M	-	-	-	-13.9 M	-	-12.9 M	-11.9 M	-13.1 M	-	-20 M	-20.9 M	-17.4 M	-	-15.8 M	-17.5 M	-17.7 M	-	-12.7 M	-11.2 M	-10.4 M	-	-5.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.09 M	-	4.99 M	9.25 M	6.61 M	-	4.85 M	5.29 M	5.05 M	-	5.49 M	5.12 M	5.06 M	-	3.94 M	3.87 M	3.57 M	-	1.82 M	1.76 M	1.89 M	-	1.24 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency